Mechanical circulatory support is increasingly being used as bridge-to-transplant and
destination therapy in patients with advanced heart failure. Technologic improvements have …

Left ventricular assisted devices (LVADs) are increasingly used for management of patients
with advanced heart failure. However, infection remains one of the most commonly reported …

The use of left ventricular assist devices (LVADs) is increasingly more common as the
availability of donor organs in relation to failing hearts is outstandingly limited. Infections are …

This comprehensive review highlights the significant advancements in Left Ventricular Assist
Device (LVAD) therapy, emphasizing its evolution from the early pulsatile flow systems to the …

Heart transplantation and durable left ventricular assist devices (LVADs) represent two
definitive therapies for end-stage heart failure in the modern era. Despite technological …

BACKGROUND Transplant recipients commonly harbor multidrug-resistant organisms
(MDROs), as a result of frequent hospital admissions and increased exposure to …

Patients on mechanical circulatory support are prone to infections, increasing morbidity and
mortality. These circulatory support devices generate high mechanical shear stress (HMSS) …

Background Ascertaining involvement of left ventricular assist device (LVAD) in a patient
presenting with bloodstream infection (BSI) can be challenging, frequently leading to use of …

Background: In view of the role of mechanical circulatory support in patients with severe
cardiac insufficiency during perioperative period, we searched the relevant articles on …

Patients undergoing heart transplantation (HTx) with active infection of left ventricular assist
devices (LVAD) are at high risk for postoperative infections. Between 2021 and 2022, five …